SEC Form 4 · accession 0000899243-17-006623
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Mark J Levin
10% Owner
Robert I Tepper
10% Owner
Kevin P Starr
10% Owner
Third Rock Ventures II, L.P.
10% Owner
Third Rock Ventures III, L.P.
10% Owner
Third Rock Ventures GP II, L.P.
10% Owner
TRV GP II, LLC
10% Owner
TRV GP III, LLC
10% Owner
Third Rock Ventures GP III, L.P.
10% Owner
Period of report
Mar 2, 2017
Accepted (ET)
Mar 6, 2017 · 7:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2017 | S | 1,000,000 | $25.50 | D | 6,475,191 | D | |
| Common StockF2 | Mar 2, 2017 | S | 1,000,000 | $25.50 | D | 285,713 | D | |
| Common StockF3,F4 | Mar 2, 2017 | S | 27,115 | $26.952 | D | 164,387 | D | |
| Common StockF5,F4 | Mar 2, 2017 | S | 7,279 | $27.686 | D | 157,108 | D | |
| Common StockF6,F4 | Mar 2, 2017 | S | 10,900 | $28.729 | D | 146,208 | D | |
| Common StockF7 | holding | — | — | — | 82,544 | D | ||
| Common StockF8 | holding | — | — | — | 191,501 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are directly held by Third Rock Ventures II, L.P. ("TRV II"). The general partner of TRV II is Third Rock Ventures GP II, L.P. ("TRV GP II"). The general partner of TRV GP II is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- F2These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Levin, Starr and Tepper. Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- F3This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.35 to $27.30, inclusive. Levin undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5) and (6) to this Form 4.
- F4These shares are directly held by Levin.
- F5This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.35 to $28.275, inclusive.
- F6This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.50 to $28.975, inclusive.
- F7These shares are directly held by Starr.
- F8These shares are directly held by Tepper.